SNS Financial Group’s Medtronic MDT Stock Holding History

SNS Financial Group’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-200	Closed	-$23K	–	219
2020 Q4	$23K	Buy	+200	New	+$22K	﹤0.01%	205

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

SNS Financial Group's MDT Position: Q2 2026 in Review

SNS Financial Group increased its Medtronic (MDT) stake by 147% in Q2 2026, buying an estimated $1.9M and bringing the position to 39,438 shares worth $3.09M. The position accounts for 0.06% of the portfolio, ranked #186.

SNS Financial Group first reported a position in MDT in Q1 2015 and has held it in 45 quarters since. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

SNS Financial Group held 39,438 shares of Medtronic worth $3.09M as of Q2 2026.
SNS Financial Group bought 23,496 Medtronic shares in Q2 2026, an estimated $1.9M.
Medtronic made up 0.06% of SNS Financial Group's portfolio in Q2 2026, its #186 holding.
SNS Financial Group first reported a position in Medtronic in Q1 2015 and has held it in 45 quarters since.
2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on SNS Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.